These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29105931)

  • 41. Medroxyprogesterone acetate inhibits wound closure of human endometrial epithelial cells and stromal fibroblasts in vitro.
    Patel MV; Rodriguez-Garcia M; Shen Z; Wira CR
    Sci Rep; 2021 Dec; 11(1):23246. PubMed ID: 34853394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group.
    Thigpen JT; Brady MF; Alvarez RD; Adelson MD; Homesley HD; Manetta A; Soper JT; Given FT
    J Clin Oncol; 1999 Jun; 17(6):1736-44. PubMed ID: 10561210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptional profiles of progestogen effects in the postmenopausal breast.
    Wood CE; Register TC; Cline JM
    Breast Cancer Res Treat; 2009 Mar; 114(2):233-42. PubMed ID: 18404370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells.
    Mitchell CM; McLemore L; Westerberg K; Astronomo R; Smythe K; Gardella C; Mack M; Magaret A; Patton D; Agnew K; McElrath MJ; Hladik F; Eschenbach D
    J Infect Dis; 2014 Aug; 210(4):651-5. PubMed ID: 24652495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of progesterone, medroxyprogesterone acetate, and norethisterone on growth factor- and estradiol-treated human cancerous and noncancerous breast cells.
    Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
    Menopause; 2005; 12(4):468-74. PubMed ID: 16037763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth.
    Nakamura M; Takakura M; Fujii R; Maida Y; Bono Y; Mizumoto Y; Zhang X; Kiyono T; Kyo S
    Cancer Lett; 2013 Aug; 336(1):68-75. PubMed ID: 23603247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-acting progestin-only contraceptives impair endometrial vasculature by inhibiting uterine vascular smooth muscle cell survival.
    Kayisli UA; Basar M; Guzeloglu-Kayisli O; Semerci N; Atkinson HC; Shapiro J; Summerfield T; Huang SJ; Prelle K; Schatz F; Lockwood CJ
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5153-8. PubMed ID: 25847994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of human endometrial transforming growth factor beta1 and beta3 isoforms through menstrual cycle and medroxyprogesterone acetate treatment.
    Reis FM; Ribeiro MF; Maia AL; Spritzer PM
    Histol Histopathol; 2002; 17(3):739-45. PubMed ID: 12168782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stimulation of arylsulfotransferase activity by progestins in human endometrium in vitro.
    Tseng L; Liu HC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):418-21. PubMed ID: 6454696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluating the impact of three progestin-based hormonal contraceptive methods on immunologic changes in the female genital tract and systemically (CHIME Study): a prospective cohort study protocol.
    Haddad LB; Herring GB; Mehta CC; Staple T; Young MR; Govindaraj S; Velu V; Smith AK
    BMC Womens Health; 2022 Nov; 22(1):456. PubMed ID: 36401326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
    Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
    J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
    Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
    Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer.
    Reed SD; Voigt LF; Beresford SA; Hill DA; Doherty JA; Weiss NS
    Am J Obstet Gynecol; 2004 Oct; 191(4):1146-51. PubMed ID: 15507934
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women.
    Wessels JM; Felker AM; Dupont HA; Kaushic C
    Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30154116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of estradiol and progestogens on human breast cells: regulation of sex steroid receptors.
    Chen FP; Chien MH; Chen HY; Huang TS; Ng YT
    Taiwan J Obstet Gynecol; 2013 Sep; 52(3):365-73. PubMed ID: 24075375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo.
    Ochnik AM; Moore NL; Jankovic-Karasoulos T; Bianco-Miotto T; Ryan NK; Thomas MR; Birrell SN; Butler LM; Tilley WD; Hickey TE
    Menopause; 2014 Jan; 21(1):79-88. PubMed ID: 23715406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV; Castro S; Marchi NM; Marcovici M; Andrade LA; Fernandes A; Bahamondes L
    Contraception; 2014 Aug; 90(2):117-22. PubMed ID: 24613369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Grwoth hormone, prolactin, and cortisol in dogs developing mammary nodules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate.
    Concannon P; Altszuler N; Hampshire J; Butler WR; Hansel W
    Endocrinology; 1980 Apr; 106(4):1173-7. PubMed ID: 6444575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sex steroids regulate epithelial-stromal cell cross talk and trophoblast attachment invasion in a three-dimensional human endometrial culture system.
    Wang H; Bocca S; Anderson S; Yu L; Rhavi BS; Horcajadas J; Oehninger S
    Tissue Eng Part C Methods; 2013 Sep; 19(9):676-87. PubMed ID: 23320930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Modulation of aromatase activity in human endometrial stromal cells by steroids, tamoxifen and RU 486.
    Tseng L; Mazella J; Sun B
    Endocrinology; 1986 Apr; 118(4):1312-8. PubMed ID: 2936597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.